EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bifidobacterium animalis subsp. lactis BB-12 attenuates diabetic retinopathy through gut microbiota modulation: evidence for the gut–retinal axis

Jiayi Lin, Yaqi Cheng, Yumin Ling, Simin Gu, Haocheng Zhu, Meng Li, Huan Yu, Jianbing Li, Qian Luo, Weihua Li, Shiqi Ling

Frontiers in Cellular and Infection Microbiology · 06.11.2025 · 15

DOI: 10.3389/fcimb.2025.1681943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.11.2025. Verfasst von Jiayi Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Gastrointestinal Microbiome, Probiotics, Bifidobacterium animalis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Previous studies have shown that Bifidobacterium animalis subsp. lactis BB-12 plays a role in maintaining the intestinal barrier and regulating inflammation; however, its potential connection to ocular diseases has not been thoroughly explored. Diabetic retinopathy (DR) is a common ocular complication of diabetes and is closely associated with metabolic dysregulation. This study investigated whether BB-12 supplementation could affect systemic diabetic symptoms, the progression of DR, and the stability of gut microbiota. Materials and methods Diabetic db/db mice were utilized to monitor metabolic parameters, assess hepatic and lipid profiles, evaluate retinal function via ERG, and examine retinal morphology through OCT and HE staining. Treg/Th17 balance was analyzed by flow cytometry, and gut microbiota composition was profiled using 16S rRNA sequencing.

Results

The results showed that BB-12 reduced obesity, decreased hepatic steatosis, improved retinal blood vessel health and vision, and influenced both the Treg/Th17 balance and gut dysbiosis in diabetic mice.

Conclusions

These findings lay the groundwork for regulatory role of intestinal microbiota on systemic and ocular complications of diabetes, and further examination of the gut-retina axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyGastrointestinal MicrobiomeProbioticsBifidobacterium animalisRetinaAnimalsMiceRNA, Ribosomal, 16SDysbiosisDisease Models, AnimalT-Lymphocytes, RegulatoryMice, Inbred C57BLTh17 CellsMaleDiabetes Mellitus, ExperimentalObesity

Stichwörter der Autor:innen

diabetesgut-retina axisintestinal microbiotaprobioticsretinopathy

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China.
  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, China.

Zitieren

APA

Lin, J., Cheng, Y., Ling, Y., Gu, S., Zhu, H., Li, M., Yu, H., Li, J., Luo, Q., Li, W., & Ling, S. (2025). Bifidobacterium animalis subsp. lactis BB-12 attenuates diabetic retinopathy through gut microbiota modulation: evidence for the gut–retinal axis. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1681943

Vancouver

Lin J, Cheng Y, Ling Y, Gu S, Zhu H, Li M, et al. Bifidobacterium animalis subsp. lactis BB-12 attenuates diabetic retinopathy through gut microbiota modulation: evidence for the gut–retinal axis. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1681943

BibTeX
@article{Lin2025,
  author = {Lin, Jiayi and Cheng, Yaqi and Ling, Yumin and Gu, Simin and Zhu, Haocheng and Li, Meng and Yu, Huan and Li, Jianbing and Luo, Qian and Li, Weihua and Ling, Shiqi},
  title = {Bifidobacterium animalis subsp. lactis BB-12 attenuates diabetic retinopathy through gut microbiota modulation: evidence for the gut–retinal axis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1681943}
}
Kostenlos starten →